Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.>> Learn more…
Free White Paper
ChinaBio In the News
"Pharma in China Being Held to Higher Standard, Says Greg Scott, ChinaBio"
As a guest to ChinaBio® Today, you have access to summaries of over 2500 articles including our archives. You can use the Search feature on the left menu bar to find what you're looking for, or you can browse summaries of our articles by the categories listed under Subscriber Articles. You can access any article that is marked as FREE. Or you can subscribe and have access to our entire content.
Bayer Buys Dihon, a China OTC/TCM Pharma | February 27, 2014
BGI Rumored to Stage $400 Million IPO in Late 2014 | February 24, 2014
Fosun Pharma and TPG Pay $369 Million for Chindex | February 17, 2014
China Pharma Foreign Trade Climbed 10% in 2013 | February 11, 2014
Luye Pharma to Conduct $750 Million Hong Kong IPO | February 10, 2013
Mindray Medical Acquires US-China IVD Company | January 30, 2013